Esther van Woudenbergh

5PUBLICATIONS
23CO-AUTHORS
Innate immunityApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Biologically active molecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Jun 11, 2026
Bacterial targeting of the neutrophil inhibitory receptor LILRB3 to evade antibody immunity.

|Sep 24, 2025
Primary human nasal, nasopharyngeal, and bronchial epithelia show distinct immune responses to various pathogens.

Esther van Woudenbergh, Anke J Lakerveld, Niels van Heerbeek

|Aug 22, 2024
Fc-engineered antibodies promote neutrophil-dependent control of Mycobacterium tuberculosis.

Edward B Irvine, Angel Nikolov, Mehak Z Khan

|Mar 06, 2021
Berberine and Obatoclax Inhibit SARS-Cov-2 Replication in Primary Human Nasal Epithelial Cells In Vitro.

Finny S Varghese, Esther van Woudenbergh, Gijs J Overheul

|Jan 10, 2020
The Orphan Immune Receptor LILRB3 Modulates Fc Receptor-Mediated Functions of Neutrophils.

Yuxi Zhao, Esther van Woudenbergh, Jing Zhu

Pageof 1

Frequent Collaborators

2 joint publications

Gerco den Hartog

2 joint publications

Jos A G van Strijp

2 joint publications

Alex J McCarthy

1 joint publications

A J Lakerveld